take a guess ?, page-12

Better watch closely Eagle as when these biotechs spike they do so very rapidly. And fall almost as rapidly too!

Don't underestimate the effect DNDN will have - it is the first in line to come to market with individualised patient specific vaccine for cancer. If they can prove it works at a level that makes a real difference that is truly a ground-breaking event, and will demonstrate that Prima has technology that is believable.

It will add a huge credibility boost to Prima and it will be seen for what it is (assuming positive outcome for DNDN) - a relatively unknown antipodean player about to burst onto the world stage. SP then? It'll make rises so far look like childs play.